| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 41.08B | 41.76B | 40.44B | 37.54B | 35.45B | 31.80B |
| Gross Profit | 10.16B | 11.19B | 9.72B | 9.83B | 11.03B | 10.22B |
| EBITDA | 21.18B | 21.67B | 20.48B | 17.75B | 18.30B | 17.40B |
| Net Income | 10.04B | 10.46B | 9.71B | 8.45B | 9.39B | 9.08B |
Balance Sheet | ||||||
| Total Assets | 123.58B | 125.79B | 122.41B | 116.08B | 124.89B | 110.43B |
| Cash, Cash Equivalents and Short-Term Investments | 22.10B | 21.87B | 17.44B | 17.16B | 32.56B | 26.85B |
| Total Debt | 18.37B | 17.47B | 19.17B | 18.79B | 25.04B | 26.02B |
| Total Liabilities | 29.51B | 30.88B | 31.26B | 29.30B | 44.36B | 37.58B |
| Stockholders Equity | 93.91B | 94.76B | 91.03B | 86.72B | 80.29B | 72.85B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 13.65B | 8.24B | -1.15B | 9.31B | 4.13B |
| Operating Cash Flow | 0.00 | 19.90B | 16.10B | 12.80B | 14.68B | 14.37B |
| Investing Cash Flow | 0.00 | -12.82B | -8.63B | -8.69B | -14.84B | -10.82B |
| Financing Cash Flow | 0.00 | -8.70B | -5.36B | -8.32B | -2.76B | 2.20B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥133.77B | 17.24 | ― | 1.78% | 2.28% | 4.19% | |
75 Outperform | ¥340.71B | 8.52 | 21.12% | 4.08% | -6.57% | -7.43% | |
64 Neutral | ¥380.07B | 17.60 | 10.65% | 1.64% | 5.49% | 3.58% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
61 Neutral | ¥247.67B | 12.92 | ― | 1.51% | ― | ― | |
53 Neutral | ¥122.52B | 43.10 | ― | 0.49% | 6.95% | 66.30% | |
48 Neutral | ¥63.07B | -8.97 | -78.01% | ― | 4.03% | -747.77% |